Prognostic factors of clinical responses in patients with advanced-stage intrahepatic cholangiocarcinoma following Atractylodes lancea administration: A phase 2A clinical trial
Teerachat Saeheng, Juntra Karbwang, Anurak Cheomung, Nisit Tongsiri, Tullayakorn Plengsuriyakarn, Kesara Na-Bangchang
doi: https://doi.org/10.1101/2023.03.28.23287855
Teerachat Saeheng
aCenter of Excellence in Pharmacology and Molecular Biology of Malaria and Cholangiocarcinoma, Chulabhorn International College of Medicine, Thammasat University (Rangsit Campus), Pathumthani, Thailand
Juntra Karbwang
bDrug Discovery and Development Center, Office of Advanced Science and Technology, Thammasat University (Rangsit Campus), Thailand
Anurak Cheomung
cGraduate Program in Bio-clinical Sciences, Chulabhorn International College of Medicine, Thammasat University, Pathumthani 12120, Thailand
Nisit Tongsiri
dSakon Nakorn Hospital, Sakon Nakorn 47000, Thailand
Tullayakorn Plengsuriyakarn
cGraduate Program in Bio-clinical Sciences, Chulabhorn International College of Medicine, Thammasat University, Pathumthani 12120, Thailand
Kesara Na-Bangchang
aCenter of Excellence in Pharmacology and Molecular Biology of Malaria and Cholangiocarcinoma, Chulabhorn International College of Medicine, Thammasat University (Rangsit Campus), Pathumthani, Thailand
bDrug Discovery and Development Center, Office of Advanced Science and Technology, Thammasat University (Rangsit Campus), Thailand
Article usage
Posted March 29, 2023.
Prognostic factors of clinical responses in patients with advanced-stage intrahepatic cholangiocarcinoma following Atractylodes lancea administration: A phase 2A clinical trial
Teerachat Saeheng, Juntra Karbwang, Anurak Cheomung, Nisit Tongsiri, Tullayakorn Plengsuriyakarn, Kesara Na-Bangchang
medRxiv 2023.03.28.23287855; doi: https://doi.org/10.1101/2023.03.28.23287855
Prognostic factors of clinical responses in patients with advanced-stage intrahepatic cholangiocarcinoma following Atractylodes lancea administration: A phase 2A clinical trial
Teerachat Saeheng, Juntra Karbwang, Anurak Cheomung, Nisit Tongsiri, Tullayakorn Plengsuriyakarn, Kesara Na-Bangchang
medRxiv 2023.03.28.23287855; doi: https://doi.org/10.1101/2023.03.28.23287855
Subject Area
Subject Areas
- Addiction Medicine (319)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2328)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11672)
- Forensic Medicine (10)
- Gastroenterology (690)
- Genetic and Genomic Medicine (3666)
- Geriatric Medicine (344)
- Health Economics (629)
- Health Informatics (2350)
- Health Policy (923)
- Hematology (338)
- HIV/AIDS (767)
- Medical Education (363)
- Medical Ethics (103)
- Nephrology (395)
- Neurology (3421)
- Nursing (193)
- Nutrition (515)
- Oncology (1792)
- Ophthalmology (530)
- Orthopedics (212)
- Otolaryngology (284)
- Pain Medicine (228)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1018)
- Primary Care Research (413)
- Public and Global Health (6067)
- Radiology and Imaging (1247)
- Respiratory Medicine (818)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (394)
- Toxicology (50)
- Transplantation (171)
- Urology (144)